SMCypI C31

Overview

SMCypI C31 is a non-peptidic cyclophilin inhibitor with potent peptidyl-prolyl cis/trans isomerases (PPIase) inhibitory activity ( IC 50 of 0.1 µM). SMCypI C31 shows pangenotype anti- HCV activity with EC 50 s ranging from 1.20 to 7.76 μM for genotype 1a, 1b, 2a, 3a, and 5a HCV subgenomic replicons (HCV-SGRs) and chimeric genotype 2a/4a HCV-SGRs. SMCypI C31 disrupts the cyclophilin A-NS5A interaction.

Application

Products | Products > Disease Areas > Infection | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Cyclophilin | Products > Signaling Pathways > HCV

Product Information

• Catalog No.: HY-125182
• CAS No.: 2649904-85-6
• Molecular Formula: C27H30N4O2S
• Molecular Weight: 474.62
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source